BDX (Becton, Dickinson and Company) Stock Financials & Earnings

BDXBecton, Dickinson and Company

Mkt Cap$60B

Revenue (TTM)$21.9B

Net Income (TTM)$1.8B

EPS (TTM)$6.13

Free Cash Flow (TTM)$2.6B

Gross Margin45.8%

Op. Margin12.4%

Net Margin8.0%

FCF Margin12.0%

P/S Ratio (TTM)2.7x

P/E Ratio (TTM)34.2x

YoY Rev Growth+6.2%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q2 23	$4.8B	$2.2B	$628M
Q3 23	$4.9B	$2.1B	$549M
Q4 23	$5.1B	$1.7B	$349M
Q1 24	$4.7B	$2.0B	$439M
Q2 24	$5.0B	$2.3B	$734M
Q3 24	$5.0B	$2.3B	$602M
Q4 24	$5.4B	$2.5B	$622M
Q1 25	$5.2B	$2.2B	$453M
Q2 25	$5.3B	$2.3B	$546M
Q3 25	$5.5B	$2.6B	$882M
Q4 25	$5.9B	$2.8B	$697M
Q1 26	$5.3B	$2.3B	$594M

Revenue Breakdown

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q2 23	$337M	—	$1.2B
Q3 23	$306M	—	$1.2B
Q4 23	$281M	—	$1.1B
Q1 24	$290M	—	$1.2B
Q2 24	$299M	—	$1.2B
Q3 24	$299M	—	$1.2B
Q4 24	$302M	—	$1.3B
Q1 25	$343M	—	$1.3B
Q2 25	$302M	—	$1.3B
Q3 25	$297M	—	$1.3B
Q4 25	$322M	—	$1.4B
Q1 26	$318M	$1.4B	—

Revenue Segments

Quarter	Interventional	Life Sciences	Medical
Q2 23	$1.2B	$1.3B	$2.4B
Q3 23	$1.2B	$1.2B	$2.4B
Q4 23	$1.2B	$1.3B	$2.6B
Q1 24	$1.2B	$1.3B	$2.2B
Q2 24	$1.3B	$1.3B	$2.4B
Q3 24	$1.2B	$1.3B	$2.6B
Q4 24	$1.3B	$1.3B	$2.8B
Q1 25	$1.3B	$1.3B	$2.6B
Q2 25	$1.3B	$1.2B	$2.8B
Q3 25	$1.3B	$1.3B	$2.9B
Q4 25	$1.4B	$1.4B	$3.2B

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 23	$2.0B	$6M	$2.0B
Q3 23	$923M	$8M	$931M
Q4 23	$1.4B	$8M	$1.4B
Q1 24	$1.2B	$2M	$1.2B
Q2 24	$2.3B	$827M	$3.2B
Q3 24	$4.5B	$851M	$5.3B
Q4 24	$1.9B	$445M	$2.3B
Q1 25	$711M	$17M	$728M
Q2 25	$667M	$16M	$683M
Q3 25	$735M	$22M	$757M
Q4 25	$851M	$8M	$859M
Q1 26	$1.0B	$11M	$1.0B

Shares Outstanding

Revenue Per Employee

Revenue / Employee